Every Ocrevus assistance program you may qualify for - manufacturer and foundation programs, not a discount card. About a minute, no login.
Every Ocrevus program linked to its official source, with the date we checked it - rules, income limits, and application links included.
Tell us five things. We’ll do the rest.
Ocrevus (ocrelizumab) is an anti-cd20 monoclonal antibody made by Roche / Genentech. It is commonly prescribed for: Relapsing forms of multiple sclerosis, Primary progressive multiple sclerosis.
Income limits
1 of the 2 active Ocrevus assistance programs we track caps household income. The lowest cutoff is $150,000 a year for a single person.
The Genentech Patient Foundation - Ocrevus uses dollar income limits instead: $150,000 for households of up to 4 people, plus $25,000 for each additional member.
Each program makes the final eligibility decision - confirm on the official application linked above.
Ocrevus offers more than one kind of program, and they have opposite rules:
We show both programs, and the real income limits, below. Or read the full copay card vs patient assistance guide
This is the full list before we filter by your situation. Use the calculator above to see only the ones you may qualify for.
Genentech, Inc. (Roche) · Ocrevus
Patient pays: as little as $0 per OCREVUS administration
commercial insurance
How to apply: online or phone
Genentech, Inc. (Roche) · Ocrevus
uninsured · underinsured
How to apply: online or phone
Your prescriber signs part of the form.
Keep tabs on Ocrevus assistance
We recheck every program’s rules on a regular schedule - income limits, eligibility, and whether a program is still open all change without much notice. Leave your email and we’ll send a short note if something changes for Ocrevus.
Yes. Genentech, Inc. (Roche) runs the Genentech Patient Foundation - Ocrevus, which provides Ocrevus free of charge to eligible patients. The full rules and the official application link are in the program list above.
Medicare coverage for Ocrevus depends on your own plan: depending on how it is given, a drug can fall under Part B (administered in a clinic) or Part D (filled at a pharmacy), and each plan decides what it covers. Your plan's documents or Medicare's plan finder are the only reliable check. Separate from coverage, none of the Ocrevus assistance programs we track currently accept Medicare patients.
Yes - the OCREVUS Co-pay Program from Genentech, Inc. (Roche). Eligible patients pay as little as $0 per OCREVUS administration. It works for patients with commercial (private) insurance. Patients on Medicare or Medicaid cannot use the card itself. If you searched for an Ocrevus coupon, this manufacturer card is the official version of it.
The official application form for the Genentech Patient Foundation - Ocrevus is on ocrevus.com - the application links on this page go straight to the program's own form. Some programs call it an enrollment form; it is the same document. Applying is always free; never pay a third-party service to file a patient assistance form for you.
None of the Ocrevus programs we track currently accept Medicare or Medicaid. If that changes, we will update this page.
Manufacturers like Roche / Genentech use "patient support program" as an umbrella term for nurse lines, insurance navigation, and financial help. The financial help is what we track here - for Ocrevus that is the Genentech Patient Foundation - Ocrevus. The support phone line is listed on the official program site linked above.